Health In Tech, Inc.
HIT
$1.51
$0.064.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 53.09% | 90.41% | 86.18% | 56.39% | -5.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 53.09% | 90.41% | 86.18% | 56.39% | -5.98% |
| Cost of Revenue | 205.27% | 241.60% | 208.20% | 168.67% | 16.30% |
| Gross Profit | 8.72% | 47.84% | 56.66% | 29.51% | -10.95% |
| SG&A Expenses | 17.42% | 90.12% | 79.21% | 42.55% | 62.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.09% | 98.92% | 92.25% | 57.21% | 38.82% |
| Operating Income | 46.00% | 12.44% | 35.56% | 44.61% | -121.73% |
| Income Before Tax | -300.81% | 47.58% | 107.65% | 257.02% | -107.48% |
| Income Tax Expenses | -522.75% | 382.08% | 220.06% | 103.73% | -93.01% |
| Earnings from Continuing Operations | -109.85% | 20.23% | 86.57% | 396.12% | -114.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -109.85% | 20.23% | 86.57% | 396.12% | -114.39% |
| EBIT | 46.00% | 12.44% | 35.56% | 44.61% | -121.73% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -89.29% | 9.59% | 75.38% | 378.95% | -118.92% |
| Normalized Basic EPS | -276.92% | 34.69% | 95.83% | 239.13% | -109.49% |
| EPS Diluted | -19.05% | 9.59% | 53.85% | 378.95% | -156.76% |
| Normalized Diluted EPS | -276.92% | 30.61% | 95.83% | 226.09% | -109.49% |
| Average Basic Shares Outstanding | 9.34% | 9.01% | 6.98% | 5.51% | -22.94% |
| Average Diluted Shares Outstanding | 9.34% | 13.53% | 7.46% | 10.10% | -22.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |